Ranbaxy inks consent decree & prepares for $500m penalty
Ranbaxy has signed a consent decree with the US FDA and set aside $500m for penalty payments to settle its longstanding dispute.
Archives for December 21, 2011
Europe’s IMI adopts CDISC standards for research projects
Europe’s Innovative Medicines Initiative (IMI) has adopted the Clinical Data Interchange Standards Consortium’s (CDISC) standards for all future projects in a move announced this week.
Warnex to sell analytical services business
Warnex is to sell its analytical services division to an unnamed private company in the latest move in a drastic restructuring programme.
PBI inks Clinigene deal to bring biomarker services to India
PBI has inked a deal with Clinigene to establish a presence in India for its biomarker and laboratory services.
US scientists develop 'light up' delivery monitoring tech
Intracellular drug delivery testing could become quicker thanks to probes that "light up" when a medicine is delivered to a tumour.
Lonza adds small moleclue capacity at Nansha plant
Lonza has expanded small molecule production capacity at its plant in Nansha, China to meet demand for clinical trial materials.
BASi posts 1st full year profit since 2007 despite Q4 loss
BASi posted its first full year net profit since 2007, despite a fourth quarter loss, and is seeking to expand its services with acquisitions.
API Christmas everybody! - Top 10 API related developments in 2011
It’s been a busy year for API (active pharmaceutical ingredient) manufacturers with new facilities, cost pressures and regulatory developments all hitting the headlines.And it seems recent developments in HPAPIs (high potency APIs) have caused a stir...